BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36136328)

  • 1. Association of Intraoperative Frozen Section Controls With Improved Margin Assessment During Transoral Robotic Surgery for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Yu AC; Afework DD; Goldstein JD; Abemayor E; Mendelsohn AH
    JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1029-1037. PubMed ID: 36136328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma.
    Magliocca KR; Kaka AS; Barrow EM; Studer MB; Griffith CC; Ernst J; Meade T; Balicki A; Boyce BJ; Schmitt NC; Bur AM; Schmitt AC; Jackson R; Steuer CE; Beitler JJ; Patel MR
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):80-87. PubMed ID: 36538901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
    Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
    J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
    Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
    Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
    Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
    JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population.
    Viros Porcuna D; Pollan Guisasola C; Viña Soria C; Cirauqui Cirauqui B; Pardo Muñoz L; Collurá F; Mesia Nin R
    Clin Transl Oncol; 2020 Aug; 22(8):1303-1311. PubMed ID: 31858433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Margins by Oropharyngeal Subsite in Transoral Robotic Surgery for T1/T2 Squamous Cell Carcinoma.
    Persky MJ; Albergotti WG; Rath TJ; Kubik MW; Abberbock S; Geltzeiler M; Kim S; Duvvuri U; Ferris RL
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):660-666. PubMed ID: 29182490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Deep Initial Incision Margin Affects Outcomes in TORS for HPV+ Oropharynx Cancer.
    Kejner A; Gentile C; Porterfield Z; Carroll WR; Buczek EP
    Laryngoscope; 2023 May; 133(5):1132-1137. PubMed ID: 35809041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom.
    O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V
    Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
    Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
    Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232
    [No Abstract]   [Full Text] [Related]  

  • 12. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
    Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
    Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.
    Holcomb AJ; Herberg M; Strohl M; Ochoa E; Feng AL; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Sadow P; Faquin W; Faden D; Deschler DG; Varvares MA; Lin DT; Fakhry C; Ryan WR; Richmon JD
    Head Neck; 2021 Aug; 43(8):2434-2444. PubMed ID: 33856083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transoral robotic surgery for management of cervical unknown primary squamous cell carcinoma: Updates on efficacy, surgical technique and margin status.
    Geltzeiler M; Doerfler S; Turner M; Albergotti WG; Kubik M; Kim S; Ferris R; Duvvuri U
    Oral Oncol; 2017 Mar; 66():9-13. PubMed ID: 28249654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Intraoperative Frozen Section to Assess Final Tumor Margin Status in Patients Undergoing Surgery for Oral Cavity Squamous Cell Carcinoma.
    Long SM; Mclean T; Valero Mayor C; Fitzgerald CWR; Feit NZ; Katabi N; Xu B; Cohen MA; Ganly I; Ghossein RA; Patel SG
    JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):911-917. PubMed ID: 35925571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach emphasising intra-operative superficial margin enhancement of head-neck tumours with narrow-band imaging in transoral robotic surgery.
    Vicini C; Montevecchi F; D'Agostino G; DE Vito A; Meccariello G
    Acta Otorhinolaryngol Ital; 2015 Jun; 35(3):157-61. PubMed ID: 26246659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specimen oriented intraoperative margin assessment in oral cavity and oropharyngeal squamous cell carcinoma.
    Horwich P; MacKay C; Bullock M; Taylor SM; Hart R; Trites J; Geldenhuys L; Williams B; Rigby MH
    J Otolaryngol Head Neck Surg; 2021 Jun; 50(1):37. PubMed ID: 34154663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
    Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes.
    Warner L; O'Hara JT; Lin DJ; Oozeer N; Fox H; Meikle D; Hamilton D; Iqbal MS; Robinson M; Paleri V
    Oral Oncol; 2022 Jul; 130():105909. PubMed ID: 35636080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.